Rise develops nanotechnology eyewear solutions. Its filtering system blocks harmful sunlight wavelengths, reducing the risk of diabetes-related eye diseases, such as cataracts and retinopathy. Rise's technology can benefit the public at large, providing protection against harmful wavelengths in a wide variety of applications. Rise's patented, second-generation solution uses advanced nanotechnology to effectively block harmful UV, blue light, and diabetes-spectrum wavelengths and reduce light intensity, using transparent lenses that do not require tinting. The nanotechnology solution successfully prevents the development and progress of diabetes-related cataracts and retinopathy.